ClinicalTrials.gg
TerminatedNCT00373633Updated Aug 15, 2014

Extrapleural Intercostal Catheter vs. Thoracic Epidural for Thoracotomy Pain

A Phase 1 interventional study of Thoracic Epidural and Extrapleural Intercostal Catheter in THoracotomy, sponsored by Virginia Commonwealth University. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-08-15.

Sponsored by Virginia Commonwealth University · Phase 1, Interventional, and Health services research

Why this study was terminated
terminated due to diminishing frequency of thorocotomies and slow enrollment
Phase
Phase 1
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

We will compare thoracic epidural anesthesia which is presently used for management of pain after thoracotomy to an intra-operatively placed extrapleural intercostal catheter. The study wil be double blinded and prospective.

Read the detailed description

The aim of this study is to evaluate the efficacy of thoracic epidural vs. continuous extra-pleural intercostal local anesthesia for the treatment of post thoracotomy pain in adult patients. Study patients will be randomized between the thoracic epidural and continuous extrapleural catheter groups[Figure 1]. Because thoracic epidural anesthesia is the gold standard but continuous extrapleural intercostal local anesthesia is potentially easier and less prone to complications, the study will be structured as an "equivalence study". The null hypothesis (Ho) is that continuous intercostal nerve blockade is worse than epidural for post-thoracotomy pain management. Therefore, the alternative hypothesis (Ha) is then that continuous intercostal nerve blockade is equal to or better than epidural for post-thoracotomy pain management.

02

Conditions studied

  • THoracotomy

Keywords

  • THoracic Surgery
  • thoracic epidural
  • epidural
  • thoracotomy
  • intercostal nerve block
  • intercostal
  • nerve block
03

In context

Lead sponsor

Virginia Commonwealth University is the lead sponsor of 648 studies on the registry; 82 are open to participants now.

Of its 90 completed or terminated interventional studies of FDA-regulated products, 64 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Unilateral thoracotomy
  • Video Assisted thoracotomy with high likely hood of converting to open thoracotmoy

Exclusion criteria

Exclusion Criteria:

  • Bilateral thoracotomy
  • Planned bilateral thoracotomy
  • Planned chest wall resection
  • Planned combined thoracotomy and laparotomy procedure
  • VATS procedure without conversion to unilateral thoracotomy
  • Emergency operation
  • Critically ill patients
  • Patients who require an assistive device (i.e. cane, walker, or wheel chair) for mobility
  • Patients who are unable to give informed consent
  • Patients with preoperative chronic back or chest wall pain
  • Empyema or other infective condition increasing the risk of epidural infection
  • Coagulopathy
  • Decision of the surgeon or anesthesiologist, or choice of the patient
  • Infection at site of epidural placement
  • Patients with other co morbidities which exclude thoracic epidural placement
  • Patients under the age of 18 years
05

Study design

Phase
Phase 1
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Continuous extra-pleural intercostal local anesthesia

    intra-operatively placed extrapleural intercostal catheter

    Procedure: Extrapleural Intercostal Catheter

  • Active comparator
    Thoracic Epidural

    gold standard

    Procedure: Thoracic Epidural

Interventions

  • ProcedureThoracic Epidural

    Gold standard for post thoracotomy pain

  • ProcedureExtrapleural Intercostal Catheter

    Continuous extra-pleural intercostal local anesthesia

06

What researchers measure

Primary outcomes

  1. pain control-visual analog pain score

    Time frame: post surgery monitoring

Secondary outcomes

  1. respiratory measurements (FEV1, PEF), pain score, nausea and vomiting, opiod usage as adjunct to primary treatmetn modalities

    Time frame: post surgery monitoring

07

Study locations

1 site
  • Virginia Commonwealth University
    Richmond, Virginia 23298, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00373633
Collaborators
I-Flow
Responsible party
Sponsor
First posted
Sep 8, 2006
Start date
Sep 2006
Primary completion
Jan 2012
Completion
Jan 2012
Last update
Aug 15, 2014

Study contacts

Mark Nelson, MD
principal investigator · Virgina Commonwealth University, Dept of Anesthesia
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion